Literature DB >> 11896391

How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.

Isao Matsumoto1, Mariana Maccioni, David M Lee, Madelon Maurice, Barry Simmons, Michael Brenner, Diane Mathis, Christophe Benoist.   

Abstract

Arthritis in the K/BxN mouse model results from pathogenic immunoglobulins (Igs) that recognize the ubiquitous cytoplasmic enzyme glucose-6-phosphate isomerase (GPI). But how is a joint-specific disease of autoimmune and inflammatory nature induced by systemic self-reactivity? No unusual amounts or sequence, splice or modification variants of GPI expression were found in joints. Instead, immunohistological examination revealed the accumulation of extracellular GPI on the lining of the normal articular cavity, most visibly along the cartilage surface. In arthritic mice, these GPI deposits were amplified and localized with IgG and C3 complement. Similar deposits were found in human arthritic joints. We propose that GPI-anti-GPI complexes on articular surfaces initiate an inflammatory cascade via the alternative complement pathway, which is unbridled because the cartilage surface lacks the usual cellular inhibitors. This may constitute a generic scenario of arthritogenesis, in which extra-articular proteins coat the cartilage or joint extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896391     DOI: 10.1038/ni772

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  110 in total

1.  Complement system on the attack in autoimmunity.

Authors:  John P Atkinson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 2.  Antigen-specific T cells in rheumatoid arthritis.

Authors:  Sean R Bennett; Michael T Falta; Jerry Bill; Brian L Kotzin
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

3.  Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis.

Authors:  Richard C Chou; Nancy D Kim; Christian D Sadik; Edward Seung; Yinan Lan; Michael H Byrne; Bodduluri Haribabu; Yoichiro Iwakura; Andrew D Luster
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

4.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

5.  B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1.

Authors:  Yolanda R Carrasco; Facundo D Batista
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

6.  Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity.

Authors:  Diana A Alvarez Arias; Hye-Jung Kim; Penghui Zhou; Tobias A W Holderried; Xuan Wang; Glenn Dranoff; Harvey Cantor
Journal:  Cancer Immunol Res       Date:  2013-12-31       Impact factor: 11.151

7.  Tryptase is a candidate autoantigen in rheumatoid arthritis.

Authors:  Yanyan Guo; Qiao Wu; Bing Ni; Zhirong Mou; Qiong Jiang; Yi Cao; Hui Dong; Yuzhang Wu
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

8.  Excretory/secretory proteome of the adult developmental stage of human blood fluke, Schistosoma japonicum.

Authors:  Feng Liu; Shu-Jian Cui; Wei Hu; Zheng Feng; Zhi-Qin Wang; Ze-Guang Han
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

9.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Authors:  Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel
Journal:  Clin Immunol       Date:  2008-07-26       Impact factor: 3.969

10.  Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.

Authors:  F Jouen; O Vittecoq; F Leguillou; I Tabti-Titon; J F Menard; O Mejjad; S Pouplin; P Boumier; P Fardellone; A Gayet; D Gilbert; F Tron; X Le Loët
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.